Werkgroep Cardiologische centra Nederland English

HARMONY (Follow up)

A long term, randomised, double blind, placebo-controlled study to determine the effect of albiglutide, when added to standard blood glucose lowering therapies, on major cardiovascular events in patients with Type 2 diabetes mellitus - Harmony Outcomes Trial

Middel
albiglutide
Populatie
preventie (diabetes)
Fase
III
Jaar aanvang
2015
Meer informatie
ClinicalTrials.gov